Eric Olson

Array ( [id] => 236326 [patent_doc_number] => 07595307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Polysaccharide derivatives and uses in induction of an immune response' [patent_app_type] => utility [patent_app_number] => 11/166781 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 40 [patent_no_of_words] => 28365 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595307.pdf [firstpage_image] =>[orig_patent_app_number] => 11166781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977491 [patent_doc_number] => 20050287208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Cross-linked powered/microfibrillated cellulose II' [patent_app_type] => utility [patent_app_number] => 11/159527 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8153 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287208.pdf [firstpage_image] =>[orig_patent_app_number] => 11159527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584340 [patent_doc_number] => 07449571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Halogenated aminoquinolines and oligonucleotides containing the same' [patent_app_type] => utility [patent_app_number] => 11/152510 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11612 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449571.pdf [firstpage_image] =>[orig_patent_app_number] => 11152510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020093 [patent_doc_number] => 20050222112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Use of agonists of the glucocorticosteroid and/or mineralo-corticosteroid receptors, in particular corticosteroids for the treatment of addiction' [patent_app_type] => utility [patent_app_number] => 11/148874 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6858 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222112.pdf [firstpage_image] =>[orig_patent_app_number] => 11148874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6965965 [patent_doc_number] => 20050232862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Combination therapy for the treatment of estrogen-sensitive drugs' [patent_app_type] => utility [patent_app_number] => 11/144932 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11970 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232862.pdf [firstpage_image] =>[orig_patent_app_number] => 11144932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952958 [patent_doc_number] => 20050228053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Combination therapy for the treatment of estrogen-sensitive disease' [patent_app_type] => utility [patent_app_number] => 11/144915 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11966 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228053.pdf [firstpage_image] =>[orig_patent_app_number] => 11144915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251727 [patent_doc_number] => 20050272926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Non-crystalline cellulose and production thereof' [patent_app_type] => utility [patent_app_number] => 11/142936 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7831 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272926.pdf [firstpage_image] =>[orig_patent_app_number] => 11142936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930856 [patent_doc_number] => 20050281891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Testosterone stimulant' [patent_app_type] => utility [patent_app_number] => 11/145545 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7269 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281891.pdf [firstpage_image] =>[orig_patent_app_number] => 11145545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966367 [patent_doc_number] => 07939530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Treatment of lymphoma using 10-propargyl-10-deazaaminopterin and gemcitabine' [patent_app_type] => utility [patent_app_number] => 11/568254 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6912 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939530.pdf [firstpage_image] =>[orig_patent_app_number] => 11568254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821066 [patent_doc_number] => 20060025379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Small molecule stimulators of neuronal growth' [patent_app_type] => utility [patent_app_number] => 11/140618 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24450 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025379.pdf [firstpage_image] =>[orig_patent_app_number] => 11140618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803440 [patent_doc_number] => 07423144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/137632 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 44503 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423144.pdf [firstpage_image] =>[orig_patent_app_number] => 11137632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224350 [patent_doc_number] => 20050261241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses' [patent_app_type] => utility [patent_app_number] => 11/132317 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14021 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261241.pdf [firstpage_image] =>[orig_patent_app_number] => 11132317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028911 [patent_doc_number] => 20070270358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Cosmetic and/or Pharmaceutical Composition for the Treatment of the Rosacea' [patent_app_type] => utility [patent_app_number] => 11/569317 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3714 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270358.pdf [firstpage_image] =>[orig_patent_app_number] => 11569317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056426 [patent_doc_number] => 20050277601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Anticancer biangeloyl saponins' [patent_app_type] => utility [patent_app_number] => 11/131551 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 14455 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277601.pdf [firstpage_image] =>[orig_patent_app_number] => 11131551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263791 [patent_doc_number] => 07569556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Method of use of carboxylated polysaccharides topically on the eyeball' [patent_app_type] => utility [patent_app_number] => 11/125444 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 7058 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569556.pdf [firstpage_image] =>[orig_patent_app_number] => 11125444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795879 [patent_doc_number] => 08124585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Composition for relieving discomfort' [patent_app_type] => utility [patent_app_number] => 11/125201 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7725 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124585.pdf [firstpage_image] =>[orig_patent_app_number] => 11125201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110546 [patent_doc_number] => 20050208001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'PPAR receptor activator compounds for treating cutaneous disorders/afflictions' [patent_app_type] => utility [patent_app_number] => 11/121124 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3210 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208001.pdf [firstpage_image] =>[orig_patent_app_number] => 11121124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662114 [patent_doc_number] => 20060252710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => '6-11 Bridged oxime erythromycin derivatives' [patent_app_type] => utility [patent_app_number] => 11/122251 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16362 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252710.pdf [firstpage_image] =>[orig_patent_app_number] => 11122251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070085 [patent_doc_number] => 20050245470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Anticancer biangeloyl saponins' [patent_app_type] => utility [patent_app_number] => 11/117745 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 12429 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245470.pdf [firstpage_image] =>[orig_patent_app_number] => 11117745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24474 [patent_doc_number] => 07795467 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-14 [patent_title] => 'Bioabsorbable, biobeneficial polyurethanes for use in medical devices' [patent_app_type] => utility [patent_app_number] => 11/115699 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15889 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795467.pdf [firstpage_image] =>[orig_patent_app_number] => 11115699 [rel_patent_id] =>[rel_patent_doc_number] =>)